» Articles » PMID: 35128827

Epigenetic Regulation of Nutrient Transporters in Rheumatoid Arthritis Fibroblast-like Synoviocytes

Overview
Publisher Wiley
Specialty Rheumatology
Date 2022 Feb 7
PMID 35128827
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Since previous studies indicate that metabolism is altered in rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS), we undertook this study to determine if changes in the genome-wide chromatin and DNA states in genes associated with nutrient transporters could help to identify activated metabolic pathways in RA FLS.

Methods: Data from a previous comprehensive epigenomic study in FLS were analyzed to identify differences in genome-wide states and gene transcription between RA and osteoarthritis. We utilized the single nearest genes to regions of interest for pathway analyses. Homer promoter analysis was used to identify enriched motifs for transcription factors. The role of solute carrier transporters and glutamine metabolism dependence in RA FLS was determined by small interfacing RNA knockdown, functional assays, and incubation with CB-839, a glutaminase inhibitor. We performed H nuclear magnetic resonance to quantify metabolites.

Results: The unbiased pathway analysis demonstrated that solute carrier-mediated transmembrane transport was one pathway associated with differences in at least 4 genome-wide states or gene transcription. Thirty-four transporters of amino acids and other nutrients were associated with a change in at least 4 epigenetic marks. Functional assays revealed that solute carrier family 4 member 4 (SLC4A4) was critical for invasion, and glutamine was sufficient as an alternate source of energy to glucose. Experiments with CB-839 demonstrated decreased RA FLS invasion and proliferation. Finally, we found enrichment of motifs for c-Myc in several nutrient transporters.

Conclusion: Our findings demonstrate that changes in the epigenetic landscape of genes are related to nutrient transporters, and metabolic pathways can be used to identify RA-specific targets, including critical solute carrier transporters, enzymes, and transcription factors, to develop novel therapeutic agents.

Citing Articles

Magnesium Supplementation Modifies Arthritis Synovial and Splenic Transcriptomic Signatures Including Ferroptosis and Cell Senescence Biological Pathways.

Laragione T, Harris C, Gulko P Nutrients. 2024; 16(23).

PMID: 39683640 PMC: 11644223. DOI: 10.3390/nu16234247.


Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders.

Song Y, Li J, Wu Y Signal Transduct Target Ther. 2024; 9(1):263.

PMID: 39362875 PMC: 11452214. DOI: 10.1038/s41392-024-01952-8.


Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis.

Ahmed S, Mahony C, Torres A, Murillo-Saich J, Kemble S, Cedeno M Arthritis Res Ther. 2023; 25(1):176.

PMID: 37730663 PMC: 10510293. DOI: 10.1186/s13075-023-03161-0.


Bovine tumor necrosis factor-alpha Increases IL-6, IL-8, and PGE2 in bovine fibroblast-like synoviocytes by metabolic reprogramming.

Manosalva C, Alarcon P, Quiroga J, Teuber S, Carretta M, Bustamante H Sci Rep. 2023; 13(1):3257.

PMID: 36828912 PMC: 9958177. DOI: 10.1038/s41598-023-29851-y.


Synovial tissue metabolomic profiling reveal biomarkers of synovial inflammation in patients with osteoarthritis.

Murillo-Saich J, Coras R, Meyer R, Llorente C, Lane N, Guma M Osteoarthr Cartil Open. 2022; 4(3):100295.

PMID: 36474936 PMC: 9718344. DOI: 10.1016/j.ocarto.2022.100295.


References
1.
McInnes I, Buckley C, Isaacs J . Cytokines in rheumatoid arthritis - shaping the immunological landscape. Nat Rev Rheumatol. 2015; 12(1):63-8. DOI: 10.1038/nrrheum.2015.171. View

2.
Zhang Y, Zhang Y, Sun K, Meng Z, Chen L . The SLC transporter in nutrient and metabolic sensing, regulation, and drug development. J Mol Cell Biol. 2018; 11(1):1-13. PMC: 6359923. DOI: 10.1093/jmcb/mjy052. View

3.
Zhang J, Visser F, King K, Baldwin S, Young J, Cass C . The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs. Cancer Metastasis Rev. 2007; 26(1):85-110. DOI: 10.1007/s10555-007-9044-4. View

4.
You S, Yoo S, Choi S, Kim J, Park S, Ji J . Identification of key regulators for the migration and invasion of rheumatoid synoviocytes through a systems approach. Proc Natl Acad Sci U S A. 2013; 111(1):550-5. PMC: 3890851. DOI: 10.1073/pnas.1311239111. View

5.
Oliveira P, Farinon M, Sanchez-Lopez E, Miyamoto S, Guma M . Fibroblast-Like Synoviocytes Glucose Metabolism as a Therapeutic Target in Rheumatoid Arthritis. Front Immunol. 2019; 10:1743. PMC: 6688519. DOI: 10.3389/fimmu.2019.01743. View